Shanghai SIMR Biotech Co.
Latest round
- Series C
Last raised
- Nov 2022
Total raised
- $26M
Investors
- 10
About Shanghai SIMR Biotech Co.
, Ltd is a new drug research and development company that provides new drugs for pain, inflammation, and central nervous system-related diseases. It established a R&D centre, covering more than 3,000 square meters, where it can do compound drug screening, chemical manufacture and control (CMC) research, preclinical evaluation, and clinical development. Moreover, it has branches in Guangdong, Jiangsu, Australia, and America., Ltd provides new drugs for pain, inflammation, anti-depressant, and central nervous system-related diseases. Its pipeline products, SR419, and SR750 are used for neuropathic pain, and SR1375 is used for diabetic macular edema. SR419 has entered clinical phase II, and SR750 and SR1375 have entered clinical phase I. Depression drugs, chronic pain drugs, and Alzheimer drugs have been in the discovery phase. There is a translational centre focusing on brain science and technology.
Who invested in Shanghai SIMR Biotech Co.
10 investors across 3 rounds
See all investors in Shanghai SIMR Biotech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shanghai SIMR Biotech Co.
Who invested in Shanghai SIMR Biotech Co.?
Shanghai SIMR Biotech Co. has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai SIMR Biotech Co. raised?
Shanghai SIMR Biotech Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Shanghai SIMR Biotech Co. last raise money?
Shanghai SIMR Biotech Co.'s most recent round on record is a Series C, in Nov 2022.
What does Shanghai SIMR Biotech Co. do?
, Ltd is a new drug research and development company that provides new drugs for pain, inflammation, and central nervous system-related diseases.
Where is Shanghai SIMR Biotech Co. headquartered?
Shanghai SIMR Biotech Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai SIMR Biotech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Shanghai SIMR Biotech Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Shanghai SIMR Biotech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.